Sale!

Kaletra (Lopinavir 200mg/Ritonavir 50mg)

£180.57

-28%
Kaletra contains lopinavir (200 mg) and ritonavir (50 mg). It is used to help treat HIV infection in adults and children, in combination with other HIV medicines. The two medicines work together to increase the level of lopinavir in the body, helping it block the virus from multiplying. Take it exactly as advised by your healthcare professional. Do not stop or change your dose without advice.

Kaletra (Lopinavir 200mg / Ritonavir 50mg) – Patient Guide (UK)

Kaletra is a medicine used to treat HIV (human immunodeficiency virus) infection. It contains two active ingredients: lopinavir 200mg and ritonavir 50mg. This guide explains how Kaletra works, how it’s typically used in the UK, important safety information, and practical tips to help you use it effectively.


1) Basic product information

Brand name: Kaletra
Active ingredients: Lopinavir / Ritonavir
Strength (as commonly supplied): 200mg / 50mg (per dose unit depending on formulation)
Medicine type: Antiretroviral therapy (protease inhibitor combination)

Kaletra is available in forms such as tablets and in some settings oral solution (availability can vary). Your local pharmacy can confirm the exact formulation you have.


2) How Kaletra works (mechanism of action)

Kaletra contains lopinavir, a protease inhibitor, and ritonavir, another protease inhibitor used at a low dose to “boost” lopinavir.

  • Lopinavir blocks the HIV protease enzyme. This enzyme is needed for HIV to produce mature, infectious viral particles.
  • Ritonavir slows down the breakdown of lopinavir in the body (it inhibits certain liver enzymes). This increases the concentration of lopinavir in the bloodstream, making treatment more effective.

Together, the medicines help lower the amount of HIV in your body (viral load). When HIV viral load becomes very low, immune function can improve. Kaletra works best as part of a combined antiretroviral regimen rather than alone.


3) Pharmacokinetics (how the body handles it)

“Pharmacokinetics” describes absorption, distribution, metabolism, and elimination. Key points for Kaletra include:

  • Absorption: Lopinavir/ritonavir is absorbed through the gut. Food can influence absorption.
  • Metabolism: Primarily metabolised by the liver, largely through enzymes including CYP3A4. Ritonavir strongly affects these enzymes, which is why many drug interactions can occur.
  • Elimination: Metabolites are eliminated mainly through bile and faeces.
  • Boosting effect: Ritonavir increases lopinavir exposure, helping keep drug levels within a therapeutic range.

Because Kaletra interacts with liver enzymes, it can change how other medicines are processed—and other medicines can change how Kaletra levels behave. This is why it’s vital to check all medicines you take.


4) What Kaletra is used for (typical use and indications)

Kaletra is used as an antiretroviral medicine to treat HIV infection. In routine HIV care, it is typically used:

  • As part of a combination regimen to achieve and maintain viral suppression.
  • When protease inhibitor–based options are considered appropriate by your HIV care team.

Use may depend on your previous treatment history, other drug interactions, and resistance testing results.

Important note: HIV treatment choices can vary. If you are switching regimens, your prescriber will consider past viral resistance and compatibility with your current medicines.


5) Timing and how to take Kaletra

Many people take Kaletra twice daily. The exact schedule and dose may vary by formulation, age, and treatment plan. Always follow the schedule described by your healthcare team and the instructions with your specific product.

Practical timing tips

  • Be consistent: Try to take doses at the same times each day.
  • Do not skip doses: Missing doses can allow viral replication to increase.
  • If you miss a dose: Take it as soon as you remember if it’s close to your next dose. If it’s near the next scheduled time, skip the missed dose—do not double up. If unsure, ask your pharmacist or HIV clinic.
  • Keep taking it: Even if you feel well, continue unless your clinician advises stopping.

6) Food interactions

Food can affect how much medicine your body absorbs and how quickly it reaches peak levels. In general, Kaletra is often taken to support absorption and reduce gastrointestinal effects.

Specific advice depends on the formulation (tablet vs oral solution) and your individual regimen. If you have been told to take Kaletra with meals, try to do so consistently.

  • Take with food if advised: Following consistent meal timing may improve tolerability.
  • Avoid irregular intake: Taking it on an empty stomach one day and with food another day can make blood levels less predictable for some people.

7) Alcohol and medicine interactions

Alcohol and Kaletra require careful consideration. While alcohol doesn’t necessarily “cancel out” HIV treatment, it can: increase side effects (such as nausea) and may affect the liver. Kaletra can also affect liver function in some people, so alcohol should be used cautiously.

Alcohol guidance (patient-friendly)

  • Limit alcohol: Keep it moderate and avoid binge drinking.
  • Be extra cautious if liver problems exist: If you have hepatitis or fatty liver disease, discuss alcohol limits with your clinician.
  • Watch for symptoms: Tell your healthcare team promptly if you develop yellowing of the skin/eyes, dark urine, severe fatigue, or pain in the upper abdomen.

Major medicine interactions to be aware of

The biggest interaction concern with Kaletra is due to ritonavir’s strong effects on liver enzymes (especially CYP3A). Some medicines can cause dangerous increases or decreases in lopinavir/ritonavir levels.

  • Medicines that may be strongly contraindicated: Some drugs that rely heavily on CYP3A can have serious interaction risks.
  • Common interaction categories:
    • Certain antiarrhythmics and cardiovascular medicines
    • Some anticonvulsants
    • Some antibiotics and antifungals
    • St John’s wort (a supplement) can reduce antiretroviral effectiveness
    • Some sedatives and hypnotics
    • Hormonal therapies and some steroids (depending on the drug)

Always tell your pharmacist and HIV clinic about all medicines, including: prescription medicines, over-the-counter products, inhalers, herbal remedies, and supplements.


8) Dosing (general information)

Dosing is tailored to the individual. In many adult regimens, Kaletra is used as lopinavir/ritonavir 200/50mg twice daily. However, your exact dose depends on factors such as age, formulation, treatment history, and co-medications.

Dose adjustment considerations

  • Liver impairment: Kaletra may require caution and monitoring if you have liver disease.
  • Kidney impairment: Adjustments may not be needed in the same way as for some other antiretrovirals, but clinical monitoring is still important.
  • Drug interactions: Co-administered medicines may require dose changes or alternative options.

Do not change your dose without advice from your HIV care team. If you’re starting Kaletra alongside new medicines, ask for an interaction check first.


9) Safety profile (what to expect and what to watch for)

Like all medicines, Kaletra can cause side effects. Many people experience mild to moderate effects early on, but some serious effects require prompt medical attention.

Common side effects

  • Diarrhoea
  • Nausea and vomiting
  • Indigestion, abdominal discomfort
  • Headache
  • Rash
  • Fatigue

Blood and metabolic changes

Protease inhibitors can affect cholesterol and triglycerides in some people. Your clinic may monitor:

  • Cholesterol (including LDL and HDL)
  • Triglycerides
  • Blood sugar (in some cases)

Serious but less common risks

  • Liver problems: Symptoms of liver injury include yellow skin/eyes, dark urine, severe tiredness, or right upper abdominal pain.
  • Severe skin reactions: Widespread rash, blistering, mouth sores, or fever should be assessed urgently.
  • Heart rhythm concerns: Some interactions with heart rhythm medicines may increase risk. This is why interaction screening is crucial.
  • Immune reconstitution inflammatory syndrome (IRIS): When starting effective HIV therapy, immune recovery can cause inflammatory responses to existing infections—your clinic will manage this.

When to seek urgent help

Contact urgent medical services or seek urgent assessment if you develop:

  • Signs of an allergic reaction (swelling of face/lips, trouble breathing, severe rash)
  • Severe dizziness, fainting, chest pain, or palpitations
  • Severe or persistent vomiting/diarrhoea leading to dehydration
  • Symptoms suggesting liver injury (yellowing, dark urine, severe fatigue)

10) Practical use tips

These tips can help you get the most benefit from Kaletra and reduce avoidable problems.

  • Adherence support: Use alarms, phone reminders, or pill organisers to help you take doses on time.
  • Manage gastrointestinal effects: Taking doses with food (if advised) may help nausea or diarrhoea. If diarrhoea persists, speak to your clinician—treatment may be needed.
  • Keep appointments for blood tests: Lipids, liver function, and HIV viral load are commonly monitored.
  • Check interaction risks every time: Even “simple” changes like starting a new painkiller, antibiotic, or herbal product can matter.
  • Avoid herbal supplements unless approved: Some supplements can reduce antiretroviral effectiveness (for example, St John’s wort).
  • Plan for travel: Ensure you have enough medicine for the trip, and keep it in original packaging.

11) Alternative options (what else may be used for HIV treatment)

There are many effective antiretroviral options available in the UK. Your HIV specialist chooses a regimen based on: resistance testing, previous treatment history, co-infections, kidney/liver function, and other medicines you take.

Possible alternatives to a boosted protease inhibitor approach include:

  • Integrase strand transfer inhibitors (INSTIs): Often used in modern first-line regimens due to effectiveness and tolerability.
  • Non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens: In selected circumstances.
  • Other boosted protease inhibitors: Sometimes used depending on your history and drug interaction profile.
  • Long-acting options: In some stable patients, injectable regimens may be considered by specialist teams.

If Kaletra isn’t suitable due to side effects or interactions, discuss switching options promptly with your HIV care team. Do not stop antiretroviral therapy without an alternative plan.


12) UK market and legal context (how Kaletra fits in the UK)

In the United Kingdom, HIV medicines are regulated and made available through authorised channels. Availability can be influenced by:

  • National guidance on HIV treatment
  • Local formularies and commissioning processes
  • Stock supply and manufacturer availability
  • Formulation type (tablets vs solution)

HIV care in the UK follows guidance from specialist bodies and national initiatives, with treatment selection supported by specialist HIV clinics.


13) Recent guidance and monitoring approach (high-level)

Treatment standards in the UK emphasise:

  • Rapid viral suppression using effective combinations
  • Adherence support and practical barrier reduction
  • Therapeutic monitoring (viral load and relevant blood tests)
  • Drug interaction checking, especially for boosted protease inhibitors
  • Individualised care based on resistance, comorbidities, and co-medications

Your HIV team may adjust monitoring frequency based on your stability and any co-existing conditions such as hepatitis or liver disease.


14) Delivery and availability in the UK (online pharmacy information)

Online pharmacy availability can vary by formulation and local stock levels. When ordering Kaletra, you may be asked to confirm:

  • The exact product (tablets or oral solution)
  • The required strength and dose unit
  • Your delivery address and contact details

Delivery times depend on supplier routes and courier schedules. Some medicines may have limited immediate availability; in such cases, the pharmacy may arrange sourcing or notify you of an estimated dispatch time.

For privacy and continuity of care, many UK pharmacies use discreet packaging and may offer delivery scheduling options. If you need your medicine urgently, contact the pharmacy before placing an order.


15) FAQ (frequently asked questions)

Is Kaletra the same as lopinavir alone?

No. Kaletra is a combination of lopinavir and ritonavir. Ritonavir is used to boost lopinavir levels, improving treatment effectiveness.

How quickly will it work?

Viral load often begins to fall within weeks of effective treatment, but the exact timeline varies. Your clinic will monitor your response using blood tests.

Can I take Kaletra with meals?

Often, taking Kaletra with food is recommended or helps reduce stomach upset. Follow your specific product instructions and guidance from your HIV clinic.

What should I do if I vomit after taking Kaletra?

If you vomit shortly after a dose, you may not have absorbed the full amount. Guidance depends on timing and severity—contact your pharmacist or HIV clinic for advice on whether to take an additional dose. Avoid doubling doses without guidance.

What medicines should I definitely check for interactions?

Please check all medicines and supplements with a pharmacist, especially: antifungals, antibiotics, antiarrhythmics (heart rhythm medicines), anticonvulsants, sedatives, herbal products (particularly St John’s wort), and medicines for cholesterol or diabetes. Interaction risk is an important feature of boosted protease inhibitor therapy.

Can I drink alcohol while on Kaletra?

You may be able to drink alcohol in moderation, but caution is advised—especially if you have liver disease or hepatitis. Alcohol can increase side effects and adds strain to the liver.

Will Kaletra cure HIV?

Kaletra helps control HIV infection, often to very low levels, but it is not a cure. Ongoing treatment is usually required to maintain viral suppression.

What monitoring will I need?

Your healthcare team may monitor: viral load, CD4 count (as appropriate), liver function tests, cholesterol and triglycerides, and other labs based on your health and regimen.

What if I stop taking Kaletra?

Stopping antiretroviral therapy can lead to viral rebound and loss of control over HIV. If you want to stop or switch, discuss it urgently with your HIV care team so an alternative plan is in place.


Summary

Kaletra (lopinavir/ritonavir) is an HIV antiretroviral medicine that works by blocking HIV protease and boosting lopinavir exposure with ritonavir. It is typically used as part of a combination regimen to help achieve viral suppression. Because ritonavir can interact with many other medicines and can affect liver metabolism, interaction checking is essential. Taking Kaletra consistently at the right times and often with food (if advised) can improve tolerability and effectiveness.

If you have questions about how Kaletra fits your medicines or health conditions, speak with your pharmacist or HIV clinic for personalised guidance.

Additional information

Dosage: No selection

60tab

Package: No selection

1 bottle, 2 bottle, 3 bottle